中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Cohort of Patients Infected by an Arbovirus

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态招聘中
赞助商
University Hospital Center of Martinique
合作者
Institut National de la Santé Et de la Recherche Médicale, France
Clinique Antilles-Guyane

关键词

抽象

Arbovirus refers to a group of viruses transmitted by blood-feeding arthropods. There are hundred which have been shown to cause disease in humans. The incubation period is usually limited between 1 and 15 days. The most common clinical features of infection are 4: algo-eruptive, hemorrhagic fever, neurological or arthritic afflictions.
Dengue is a mosquito-born viral disease caused by 4 different serotypes of virus. Dengue fever (DF) is defined by the sudden onset of fever with non-specific constitutional symptoms, recovery occurring spontaneously after 3 to 7 days.
The infection can sometimes progress to dengue hemorrhagic fever (DHF) characterized by a transient increase in vascular permeability provoking a plasma leakage syndrome. DHF can be complicated by shock and internal hemorrhage. Other rarer but potentially life-threatening complications include encephalitis, hepatitis, rhabdomyolysis and myocarditis.
There is currently no way of predicting the outcome of DF or DHF and the WHO classification lacks sufficient sensitivity and specificity to recognize and guide the management of severe forms of dengue. The pathophysiology of these severe forms is also poorly known.
Since the early 2000s, the French West Indies and French Guiana have become hyperendemic for dengue with simultaneous circulation of the 4 serotypes, regular large outbreak and severe dengue including fatalities.
Chikungunya is a re-emerging alphavirus causing massive epidemics in Africa, in the Indian Ocean and Southeast Asia. The first autochthonous cases were described in French Antilles in Nov. 2013. The disease consists of an acute illness like dengue fever, characterized by abrupt onset of a high-grade fever, followed by constitutionals symptoms, poly-arthritis and skin involvement. Usually, the illness resolves within 4 to 6 weeks. However, severe clinical forms in early stage may appear and chronic forms such as incapacitating arthralgia which affect 40 to 60% of patients with confirmed chikungunya. In France, others arboviruses may cause severe emerging and re-emerging infectious diseases like Zika or West Nile. In non-immunized population they may cause outbreaks with specific severe clinical complications. French interministerial mission on emerging infectious diseases, coordinated by Professor A. Flahault, recommended such studies.

描述

Principal objective To identify demographic, clinical, biological, virologic, immunologic and genetic factors associated with or predictive of severe complications of arbovirus infections (shock, internal bleeding, organ failure, death) in a cohort of children and adults with confirmed arbovirus infections, in France.

Secondary objective

To identify demographic, clinical, biological, virologic, immunologic and genetic factors predictive of altered quality of life after confirmed an acute arbovirus infection. Onset of specific complications:

- Hemorrhagic fever (dengue :WHO criteria..)

- Neurological disorders (West Nile virus infection, Zika virus infection, Japanese encephalitis…)

- Chronic chikungunya (persistent musculoskeletal symptoms for more than three months after symptoms onset)

日期

最后验证: 12/31/2018
首次提交: 02/22/2010
提交的预估入学人数: 04/05/2010
首次发布: 04/07/2010
上次提交的更新: 07/21/2019
最近更新发布: 07/23/2019
实际学习开始日期: 05/31/2010
预计主要完成日期: 06/30/2021
预计完成日期: 06/30/2021

状况或疾病

Fever
Dengue
Chikungunya
Zika Virus

干预/治疗

Other: biological sample collection

Other: quality of life questionnaire EuroQol®

Other: Health Assessment Questionnaire - MDHAQ and RAPID3

-

资格标准

有资格学习的性别All
取样方式Non-Probability Sample
接受健康志愿者
标准

INCLUSION CRITERIA :

1. Adult, child or newborn.

2. Consulting a participating hospital center (emergency room, full hospitalization, day hospitalization, or outpatient visit).

3. Arbovirosis suspected or confirmed biologically:

A suspected case of arbovirus infection is defined by:

- The combination of clinical and biological signs observed on the day of enrollment or during the previous 7 days: fever (reported by the patient or family, or documented) and two or more of the following signs: headache, rash, myalgia, arthralgia, abdominal pain, hemorrhage, thrombocytopenia, or

- Children under 6 years: the report (by family or documented) of a fever on the day of enrollment or within 7 previous days, possibly accompanied by a of pain greater than or equal to 4/10 on hetero assessment scale age age-appropriate

A case of arbovirus infection confirmed biologically is defined by:

- RT-PCR arbovirus positive in plasma or urine (Zika virus infection), or by detection of the NS1 antigen (dengue), or an appearance or an significant increase (multiplication of the title by four) of the G immunoglobulin directed against arbovirus in question on an early taken serum ( during the first week following the start of symptoms) and another taken at least 10 days later..

4. Symptom onset within the seven days before the enrollment visit or within 21 days for severe forms of the disease.Possibility of follow-up throughout study period.

5. Patient or holder of parental authority registered in the French medical social security national program

6. Acceptance to participate in the study and in follow-up; informed consent of the patient (adult and minor in age to express his desire) or a legal representative (for minors, and patients unable to sign the consent form).

EXCLUSION CRITERIA :

1. Newborn with a weight < 2.5 kg the days of enrollment

2. Suspected arbovirosis whose symptom onset date more than 7 days or 21 days for severe forms of the disease.Clinical diagnosis of another infection as arbovirosis

3. Confirmed Malaria Access

4. No follow-up possible after the first visit

5. Refusal to participate to the study

6. Patient or holder of parental authority not registered in the French medical social security national program

结果

主要结果指标

1. Occurrence, during follow-up (for 12 weeks following symptom onset), of shock, internal bleeding, failure of one or several organs or systems (brain, heart, lung, liver, kidney, clotting system), or death. [12 weeks]

The primary endpoint is a composite endpoint defined as the occurrence, within 12 weeks of the onset of arbovirosis, of at least 1 of the following events: death or shock or internal bleeding, or failure to one or more organs or systems (brain, heart, lung, liver, kidney, hemostasis). Deaths not attributable directly or indirectly to the arbovirosis in question will not be taken into account.

次要成果指标

1. Specific complications: Onset of hemorrhagic fever (dengue) Onset of encephalitis or neurological disorders (West Nile virus, Japanese encephalitis, Zika virus) Onset of chronic form (Chikungunya) [12 weeks]

The analysis will focus only on patients with biologically confirmed arbovirosis by one of the following exams: RT-PCR plasma (arbovirus), or urine (Zika virus), Research of the NS1 positive antigen (dengue), Significant appearance or increase of the G immunoglobulin directed against the arbovirus in question between an early serum (during the first week following the onset of symptoms) and another taken at least 10 days later

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge